$VRTX
VERTEX PHARMACEUTICALS INC / MA

2014 Q1 Form 10-Q Financial Statement

#000087532014000026 Filed on May 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $118.5M $328.4M
YoY Change -63.93% -25.16%
Cost Of Revenue $8.572M $30.96M
YoY Change -72.31% 19.43%
Gross Profit $109.9M $297.4M
YoY Change -63.06% -27.96%
Gross Profit Margin 92.76% 90.57%
Selling, General & Admin $74.21M $91.63M
YoY Change -19.0% -17.56%
% of Gross Profit 67.54% 30.81%
Research & Development $238.6M $210.2M
YoY Change 13.52% 7.04%
% of Gross Profit 217.16% 70.68%
Depreciation & Amortization $15.79M $10.69M
YoY Change 47.68% 24.89%
% of Gross Profit 14.37% 3.59%
Operating Expenses $312.8M $301.8M
YoY Change 3.65% -1.85%
Operating Profit -$216.0M -$429.1M
YoY Change -49.66% -568.24%
Interest Expense -$15.72M -$3.469M
YoY Change 353.07% 2212.67%
% of Operating Profit
Other Income/Expense, Net $451.0K -$1.175M
YoY Change -138.38% -68.59%
Pretax Income -$231.3M -$433.8M
YoY Change -46.68% -593.45%
Income Tax $803.0K -$126.9M
% Of Pretax Income
Net Earnings -$232.5M -$308.0M
YoY Change -24.53% -436.3%
Net Earnings / Revenue -196.25% -93.8%
Basic Earnings Per Share -$1.00 -$1.43
Diluted Earnings Per Share -$1.00 -$1.43
COMMON SHARES
Basic Shares Outstanding 232.9M shares 215.4M shares
Diluted Shares Outstanding 232.9M shares 215.4M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.324B $1.239B
YoY Change 6.86% 26.3%
Cash & Equivalents $424.0M $379.1M
Short-Term Investments $900.0M $860.0M
Other Short-Term Assets $35.00M $111.0M
YoY Change -68.47% 19.35%
Inventory $11.26M $21.53M
Prepaid Expenses
Receivables $59.86M $194.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.430B $1.566B
YoY Change -8.65% 9.04%
LONG-TERM ASSETS
Property, Plant & Equipment $726.2M $504.2M
YoY Change 44.02% 196.03%
Goodwill $30.99M $30.99M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.452M $8.693M
YoY Change 8.73% -19.63%
Total Long-Term Assets $766.8M $826.5M
YoY Change -7.22% -9.18%
TOTAL ASSETS
Total Short-Term Assets $1.430B $1.566B
Total Long-Term Assets $766.8M $826.5M
Total Assets $2.197B $2.392B
YoY Change -8.16% 1.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.57M $59.63M
YoY Change -16.86% -18.57%
Accrued Expenses $234.4M $274.1M
YoY Change -14.48% 13.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $18.00M $8.000M
YoY Change 125.0%
Total Short-Term Liabilities $373.5M $407.6M
YoY Change -8.37% 14.18%
LONG-TERM LIABILITIES
Long-Term Debt $523.0M $732.0M
YoY Change -28.55% 83.0%
Other Long-Term Liabilities $12.03M $16.68M
YoY Change -27.87% 53.22%
Total Long-Term Liabilities $12.03M $16.68M
YoY Change -27.87% 53.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $373.5M $407.6M
Total Long-Term Liabilities $12.03M $16.68M
Total Liabilities $966.2M $1.415B
YoY Change -31.73% 0.03%
SHAREHOLDERS EQUITY
Retained Earnings -$4.199B -$3.830B
YoY Change 9.65%
Common Stock $5.431B $4.577B
YoY Change 18.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.231B $746.1M
YoY Change
Total Liabilities & Shareholders Equity $2.197B $2.392B
YoY Change -8.16% 1.97%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$232.5M -$308.0M
YoY Change -24.53% -436.3%
Depreciation, Depletion And Amortization $15.79M $10.69M
YoY Change 47.68% 24.89%
Cash From Operating Activities -$175.8M -$65.78M
YoY Change 167.2% -2355.76%
INVESTING ACTIVITIES
Capital Expenditures $15.53M $16.61M
YoY Change -6.51% 169.81%
Acquisitions
YoY Change
Other Investing Activities $476.0K -$472.0K
YoY Change -200.85% -318.52%
Cash From Investing Activities -$20.40M -$37.60M
YoY Change -45.74% -83.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.40M -6.100M
YoY Change -926.23% -128.37%
NET CHANGE
Cash From Operating Activities -$175.8M -$65.78M
Cash From Investing Activities -20.40M -37.60M
Cash From Financing Activities 50.40M -6.100M
Net Change In Cash -$175.8M -$65.78M
YoY Change 167.2% -2355.76%
FREE CASH FLOW
Cash From Operating Activities -$175.8M -$65.78M
Capital Expenditures $15.53M $16.61M
Free Cash Flow -$191.3M -$82.39M
YoY Change 132.19% 2443.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
49327000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
49571000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59858000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85517000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
271077000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
234386000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-306000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-550000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1149000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5428193000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5321286000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46787000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31574000 USD
CY2014Q1 us-gaap Assets
Assets
2197108000 USD
CY2013Q4 us-gaap Assets
Assets
2319041000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
1588576000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
1430330000 USD
CY2014Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
900155000 USD
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
895777000 USD
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
18323000 USD
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
16893000 USD
CY2014Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3619000 USD
CY2013Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
49495000 USD
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
48754000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
27000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
11459000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
67818000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
569299000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
424045000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
79277000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
18576000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
12244000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
12346000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
13441000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
19979000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
379099000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489407000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
233592201 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
236201333 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
236201333 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
233592201 shares
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
2334000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2320000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-308615000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-232448000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4611000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-313226000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-232448000 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
503400000 USD
CY2014Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
525500000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8572000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30955000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
766656000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
334839000 USD
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-130300000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
30992000 USD
CY2014Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.02
CY2014Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.09
CY2013Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
127600000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21510000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28836000 USD
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
43889000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
49459000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2700000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
966800000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
66900000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10691000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15788000 USD
CY2013Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
11788000 USD
CY2014Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
6904000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
499000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-799000 USD
CY2014Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
207000 USD
CY2013Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
299000 USD
CY2013Q1 us-gaap Extraordinary Item Earnings Per Share Impact Net
ExtraordinaryItemEarningsPerShareImpactNet
1.32
CY2014Q1 us-gaap Goodwill
Goodwill
30992000 USD
CY2014Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2013Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2014Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2013Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
412900000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-231654000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-442940000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
803000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-130313000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
140000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1541000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-40571000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
978000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48834000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25237000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
23236000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-13536000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1756000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2022000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2488000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9231000 USD
CY2014Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
0 USD
CY2013Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-128703000 USD
CY2013Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-472000 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
476000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17937000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24986000 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
0 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-6975000 USD
CY2013Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3465000 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15717000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
243000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
15970000 USD
CY2014Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1822000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3677000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
14147000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
11261000 USD
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
489000 USD
CY2014Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9439000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9981000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
962636000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
966230000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2197108000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2319041000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
397829000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
373500000 USD
CY2014Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
31900000 USD
CY2014Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2013Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2013Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
342000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1187000 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
-8050000 USD
CY2014Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
380949000 USD
CY2013Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
458971000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-145254000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-110308000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
50416000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6135000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37596000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20407000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65778000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-175762000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-232457000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-308016000 USD
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4611000 USD
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2014Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
25564000 USD
CY2013Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
66052000 USD
CY2014Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-438288000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-216388000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9452000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2432000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-610000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
72000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-599000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-36000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
24736000 USD
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32473000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12030000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11590000 USD
CY2013Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
2432000 USD
CY2014Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2014Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
173000 USD
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
975000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
451000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15526000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16607000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35011000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23836000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60134000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21670000 USD
CY2013Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17709000 USD
CY2014Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-15146000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
430535000 USD
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
376544000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-312627000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-232457000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
696911000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
726204000 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10096000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2622000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238963000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
218095000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
130000 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
130000 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
39000 USD
CY2014Q1 us-gaap Restructuring Charges
RestructuringCharges
6188000 USD
CY2014Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9911000 USD
CY2013Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
14286000 USD
CY2013Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
14067000 USD
CY2014Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
13956000 USD
CY2013Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-869000 USD
CY2014Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-4486000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4199352000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3966895000 USD
CY2014Q1 us-gaap Revenues
Revenues
118451000 USD
CY2013Q1 us-gaap Revenues
Revenues
328368000 USD
CY2014Q1 us-gaap Royalty Revenue
RoyaltyRevenue
10733000 USD
CY2013Q1 us-gaap Royalty Revenue
RoyaltyRevenue
43573000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
103461000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
267381000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
92879000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74212000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
46580000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
31275000 USD
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
7318000 shares
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
16078000 shares
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
39.60
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
48.89
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y22D
CY2014Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
60134000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
24102000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
1230878000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1356405000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
937960000 USD
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1230878000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1195852000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356405000 USD
CY2013Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
120100000 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-36000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2600000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2000000 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest (Alios), the consolidation and deconsolidation of a VIE, leases and the income tax provision. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> Annual Report on Form&#160;10-K.</font></div></div>
CY2014Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
6366000 USD
CY2014Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
71657000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
87133000 USD
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215421000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232887000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232887000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215421000 shares
CY2014Q1 vrtx Amounts Reclassified From Accumulated Other Comprehensive Income Loss
AmountsReclassifiedFromAccumulatedOtherComprehensiveIncomeLoss
3000 USD
CY2013Q1 vrtx Amounts Reclassified From Accumulated Other Comprehensive Income Loss
AmountsReclassifiedFromAccumulatedOtherComprehensiveIncomeLoss
0 USD
CY2014Q1 vrtx Capital Leases Future Minimumpaymentsduein Sixyears
CapitalLeasesFutureMinimumpaymentsdueinSixyears
2664000 USD
CY2014Q1 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1324200000 USD
CY2013Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1465076000 USD
CY2014Q1 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1324185000 USD
CY2013Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1465034000 USD
CY2013Q4 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
136000 USD
CY2014Q1 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
95000 USD
CY2013Q4 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
94000 USD
CY2014Q1 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
80000 USD
CY2013Q1 vrtx Collaborative Revenues
CollaborativeRevenues
17414000 USD
CY2014Q1 vrtx Collaborative Revenues
CollaborativeRevenues
4257000 USD
CY2014Q1 vrtx Construction Financing Obligation
ConstructionFinancingObligation
473700000 USD
CY2014Q1 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
473360000 USD
CY2013Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
440937000 USD
CY2014Q1 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
59200000 USD
CY2011 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 leases
CY2011 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2011 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
CY2014Q1 vrtx Other Comprehensive Income Loss Before Reclassifications
OtherComprehensiveIncomeLossBeforeReclassifications
6000 USD
CY2013Q1 vrtx Other Comprehensive Income Loss Before Reclassifications
OtherComprehensiveIncomeLossBeforeReclassifications
-599000 USD
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2011 vrtx Square Footage Of Leased Property
SquareFootageOfLeasedProperty
1100000 squarefeet
CY2014Q1 vrtx Termof Lineof Credit Facility
TermofLineofCreditFacility
P1Y
CY2014Q1 vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
-19598000 USD
CY2014Q1 vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
-41440000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
236194337 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA

Files In Submission

Name View Source Status
0000875320-14-000026-index-headers.html Edgar Link pending
0000875320-14-000026-index.html Edgar Link pending
0000875320-14-000026.txt Edgar Link pending
0000875320-14-000026-xbrl.zip Edgar Link pending
a2014q110-q.htm Edgar Link pending
a2014q110-q_exhibit31122.htm Edgar Link pending
a2014q110-q_exhibit31222.htm Edgar Link pending
a2014q110-q_exhibit32122.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20140331.xml Edgar Link completed
vrtx-20140331.xsd Edgar Link pending
vrtx-20140331_cal.xml Edgar Link unprocessable
vrtx-20140331_def.xml Edgar Link unprocessable
vrtx-20140331_lab.xml Edgar Link unprocessable
vrtx-20140331_pre.xml Edgar Link unprocessable